Aldeyra Therapeutics Announces Second Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/1/2026
- S&P 500, Nasdaq register best quarter since 2020 despite Iran war
- Dollar pushes higher, yen sinks to 40-year low
- NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
- Citi says bearish flows are building in Nasdaq and S&P 500
- Patrick and LCI Industries to merge in all-stock deal
- S&P 500, Nasdaq register best quarter since 2020 despite Iran war
- DISH DBS files prepackaged chapter 11 to repay debt, wind down wireless
- Boeing commercial jet deliveries and production disrupted by widespread IT outage - Air Current
- Cantor Fitzgerald Starts Forward Industries (FWDI) at Overweight
- NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
Aldeyra Therapeutics (ALDX) Tops Q2 EPS by 4c
August 8, 2017 7:36 AM EDTAldeyra Therapeutics (NASDAQ: ALDX) reported Q2 EPS of ($0.35), $0.04 better than the analyst estimate of ($0.39).
For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.
... More